Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is a recognised side effect of Mounjaro (tirzepatide). Many people find they feel more tired than usual during the first few weeks of treatment, particularly after starting or increasing their dose. It typically eases as the body adjusts. That said, persistent or severe exhaustion is worth discussing with your prescriber, because Mounjaro is a prescription-only medicine and any change in how you feel deserves proper clinical attention — not a guess.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear regularly goes something like this: "I've started Mounjaro and I'm exhausted, have I done something wrong?" The assumption behind it is understandable. People expect a weight-loss medicine to energise them, so fatigue feels like a bad sign. It usually isn't.
Tiredness in the early weeks is, if anything, a signal that your body is responding to tirzepatide's dual action on GIP and GLP-1 receptors. These receptors help regulate appetite, gastric emptying and blood-sugar balance. When they're activated for the first time, there's a genuine physiological adjustment period. Your appetite drops, your stomach empties more slowly, and your body is processing fewer calories than it was a week ago. Feeling a little flat during that transition is entirely consistent with what the clinical evidence shows.
The NHS tirzepatide medicines page lists tiredness among the known side effects of Mounjaro, alongside the more frequently discussed gastrointestinal symptoms. It is not a sign of failure; it is a sign of change.
Understanding the broader side-effect picture with Mounjaro can help you tell the expected from the unexpected, which matters more than most people realise when they're a week into a new pen.
There isn't one single explanation for why Mounjaro can make you tired. Most people are dealing with two or three things at once.
Reduced energy intake. Tirzepatide is highly effective at suppressing appetite. For many people, especially in the first few weeks, that means eating significantly less than before. A meaningful calorie deficit (even a welcome one) can leave you feeling sluggish, particularly if you're not compensating with adequate protein and fluids. This is one reason prescribers and dietitians consistently stress that eating well on treatment matters as much as eating less.
Slower gastric emptying. One of tirzepatide's mechanisms is delaying how quickly food leaves your stomach. This extends the feeling of fullness but can also contribute to a kind of low-level heaviness, especially after meals. Some people describe it as feeling "foggy" rather than actively sleepy.
The body's adjustment response. Starting any new hormonal medicine involves a period of recalibration. Your gut-hormone signalling, blood-glucose fluctuations and even sleep patterns can all shift in the first weeks. Fatigue is a common feature of that recalibration, not a complication of it.
People sometimes wonder whether the tiredness is actually tied to the gastrointestinal symptoms (nausea in particular) rather than tiredness as a separate effect. There's truth in that. Feeling sick is draining. You can read more about why Mounjaro affects the gut the way it does, which gives useful context for the wider pattern of early symptoms.
For a more detailed look at the overlap between tiredness and other early-treatment symptoms, the experience of fatigue on Mounjaro page covers the topic in more depth.
For most people, fatigue is most noticeable in the days immediately after an injection or a dose increase, and then fades over the following week or two. The pattern tends to repeat, more mildly each time, as the dose steps up through the treatment schedule.
A few practical points that can make a real difference:
Timing your injection. Some people find that taking their weekly injection on a Friday evening means the peak of any side effects falls over the weekend rather than a working day. That's a practical adjustment worth considering, not a clinical instruction, discuss any changes with your prescriber first.
Hydration and protein. Dehydration amplifies fatigue considerably, and low protein intake compounds it. On a reduced appetite, it's easy to let both slip. Prioritising water and protein-rich foods is consistently the most practical thing people can do.
Dose increases. If tiredness reliably spikes after each step up, that's useful information to share with your prescriber. The titration schedule exists partly to manage tolerability; slowing it down is an option if symptoms are genuinely disruptive.
People who want to understand the specific mechanism behind why tirzepatide affects energy levels will find more on the physiological reasons tirzepatide causes tiredness page. There's also a related question some people raise about whether Mounjaro can make you feel cold as well as tired, which touches on the calorie-deficit and metabolic-rate angle.
Mild fatigue that comes and goes is expected. These are the signs that it warrants prompt attention instead.
Severe, sudden or worsening exhaustion that doesn't match the usual pattern of the first days after a dose (especially if it appears weeks into treatment without a clear trigger) is worth a call to your prescriber or GP.
Tiredness alongside severe stomach pain that radiates to the back, with or without vomiting, requires urgent medical attention. In January 2026, the MHRA issued a Drug Safety Update reminding patients and clinicians that acute pancreatitis, while uncommon, is a known serious risk with GLP-1 medicines, and that this specific pain pattern is the key warning sign. Don't wait to see if it passes.
Tiredness with significant dizziness or faintness may suggest dehydration from persistent nausea or vomiting, which can become a problem quickly. If you can't keep fluids down, contact your prescriber or 111.
Mounjaro is a prescription-only medicine reviewed by a clinician before every supply. If you're unsure whether what you're experiencing is expected, the right move is always to ask. You can also explore whether tirzepatide-related tiredness is affecting others in the same way, or read through the full Mounjaro overview for broader context on the treatment.
If you haven't started treatment yet and are weighing up how Mounjaro fits your situation, our free consultation connects you with a GPhC-registered prescriber who can talk through your specific circumstances, tiredness concerns and all.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.